Nasdaq: GTBP

Press Releases

Press Releases

GT Biopharma Appoints Two New Independent Directors

January 19, 2021

GT Biopharma Announces Eighth Patient Begins Treatment Of GTB-3550

January 12, 2021

GT Biopharma (OTCQB: GTBP) Announces Corporate Update Conference Call

January 4, 2021

GT Biopharma Announces TriKE™ For The Treatment Of Breast And GI Cancers

December 28, 2020

GT BIOPHARMA ANNOUNCES FDA DATA - GTB-3550 TriKE™ REDUCES CANCER CELLS BY 61.7% FOR A HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) PATIENT

December 21, 2020

GT Biopharma And Cytovance Biologics Announce Milestone Achievement

December 17, 2020

GT Biopharma Submits Application for Uplisting to the NASDAQ Capital Market

December 14, 2020

GT Biopharma Announces GTB-3550 TriKE(TM) Reduces Bone Marrow Blast Levels, Improves NK Cell Function and Proliferation, and No Toxicities Observed in AML and MDS Patients

December 8, 2020

GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors

November 19, 2020

GT Biopharma Appoints Michael Handelman, CPA as Chief Financial Officer

November 18, 2020